rxstatShortages › Metformin Sitagliptin

Metformin Sitagliptin (Janumet) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 24, 2026

Some Metformin Sitagliptin products are in shortage in Canada (7 of 23 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 31, 2026.

A combination of two diabetes medications used to lower blood sugar in type 2 diabetes.

Products affected
7 / 23
In shortage since
Jul 22, 2025
Est. full return
Jul 31, 2026
Reports on file
71
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
APO-SITAGLIPTIN/METFORMIN XR
100MG 1000MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02506297 · since Jun 30, 2026, est. end Jul 24, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN/METFORMIN XR
500MG 50MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02506270 · since Jul 7, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE / METFORMIN
1000MG 50MG · TABLET · TEVA CANADA LIMITED
DIN 02520516 · since Jun 10, 2026, est. end Jul 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE / METFORMIN
850MG 50MG · TABLET · TEVA CANADA LIMITED
DIN 02520508 · since Mar 10, 2026, est. end Jul 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE / METFORMIN
850MG 50MG · TABLET · TEVA CANADA LIMITED
DIN 02520508 · since Mar 10, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
50MG 1000MG · TABLET · APOTEX INC
DIN 02509431 · since Jul 22, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
850MG 50MG · TABLET · APOTEX INC
DIN 02509423 · since Sep 30, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
50MG 500MG · TABLET · APOTEX INC
DIN 02509415 · since Oct 8, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
500MG 50MG · TABLET · APOTEX INC
DIN 02509415 · since Dec 9, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
50MG 1000MG · TABLET · APOTEX INC
DIN 02509431 · since Sep 16, 2025, no end estimate · Disruption of the manufacture of the drug.
Anticipated
JANUMET XR
1000MG 100MG · TABLET (EXTENDED-RELEASE) · MERCK CANADA INC
DIN 02416808 · Disruption of the manufacture of the drug.
Anticipated
JANUMET XR
1000MG 50MG · TABLET (EXTENDED-RELEASE) · MERCK CANADA INC
DIN 02416794 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Metformin Sitagliptin is currently affected by 7 active shortage reports filed with Health Canada by APOTEX INC, TEVA CANADA LIMITED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Metformin Sitagliptin is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BD).

Recent changes

Common questions

What is Metformin Sitagliptin used for?

A combination of two diabetes medications used to lower blood sugar in type 2 diabetes.

When will Metformin Sitagliptin be back in stock in Canada?

The latest manufacturer estimate is Jul 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Metformin Sitagliptin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (blood glucose lowering drugs, excl. insulins)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.